C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 263/57 (2006.01)
Patent
CA 2685590
Provided is a process for the preparation of 5-(ethylsulfonyl)-2-(naphthalen-2-yl) benzo [d] oxazole useful in the treatment of Duchenne muscular dystrophy.
L'invention concerne un procédé de préparation d'un composé utile pour le traitement de la dystrophie musculaire de Duchenne.
Clarkson Robert
de Moor Olivier
Van Well Renate
Weymouth-Wilson Alexander Charles
Wren Stephen Paul
Biomarin Iga Limited
Osler Hoskin & Harcourt Llp
Summit Corporation Plc
LandOfFree
Treatment of duchenne muscular dystrophy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of duchenne muscular dystrophy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of duchenne muscular dystrophy will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1820225